DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bwhfcc/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Regulatory Report 2012" report to their offering.
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of India pharmaceutical regulations. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2012. As India's pharmaceutical market is poised for steady growth, reaching an estimated $13 billion, understanding of Indian regulatory issues is crucial for success.
Key Topics Covered:
I: Overview of India's Economy
II: Overview of India's Healthcare System
A. India's Healthcare System: Goals and Challenges
B. Healthcare Providers
C. Healthcare Spending
D. Conclusion
III: India's Pharmaceutical Industry
A. Market Profile
B. Industry Profile
C. Conclusion
IV: India Pharmaceutical Regulations Overview
A. Governing Legislation
B. Agencies
V: Drug Registration and Import
A. Overview
B. New Drug Registration
C. Import Registration
D. Import License
E. Adverse Event Reporting
VI. Manufacturing
A. Overview
B. Licensing
C. Good Manufacturing Practice
VII: Distribution
A. Overview
B. Licensing
C. Record-Keeping
D. Packaging and Labeling
E. Price Controls
F. Prescription Management
VIII: Clinical Trials and R&D
A. Overview
B. Restrictions on Clinical Trials
C. Global Clinical Trials
D. Licensing and Monitoring
E. Good Laboratory Practice
F. Accreditation of Testing Laboratories
IX: Intellectual Property Protection
A. History
B. Patent Applications
C. Remaining Restrictions
D. Prosecution of IP Violations
X: Drug Advertising
XI: Conclusion
For more information visit http://www.researchandmarkets.com/research/bwhfcc/india_pharmaceutic